BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32186750)

  • 1. Methylation‑associated silencing of miR‑638 promotes endometrial carcinoma progression by targeting MEF2C.
    Ni J; Liang S; Shan B; Tian W; Wang H; Ren Y
    Int J Mol Med; 2020 Jun; 45(6):1753-1770. PubMed ID: 32186750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
    Ni J; Tian W; Liang S; Wang H; Ren Y
    Int J Med Sci; 2021; 18(12):2510-2520. PubMed ID: 34104082
    [No Abstract]   [Full Text] [Related]  

  • 3. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
    Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
    PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
    Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
    Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
    He Z; Xu H; Meng Y; Kuang Y
    Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma.
    Li Q; Shen F; Zhao L
    Biomed Pharmacother; 2018 Nov; 107():918-928. PubMed ID: 30257404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression.
    Chen S; Zong ZH; Wu DD; Sun KX; Liu BL; Zhao Y
    Mol Carcinog; 2017 Apr; 56(4):1361-1371. PubMed ID: 27991682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
    Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
    Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
    Li L; Qu YW; Li YP
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.
    Bao W; Zhang Y; Li S; Fan Q; Qiu M; Wang Y; Li Y; Ji X; Yang Y; Sang Z; Xu W; Yang Y; Wu S; Zhu Y
    Oncol Rep; 2019 Mar; 41(3):1575-1585. PubMed ID: 30569100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
    Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
    Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-associated silencing of
    Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NORAD orchestrates endometrial cancer progression by sequestering FUBP1 nuclear localization to promote cell apoptosis.
    Han T; Wu Y; Hu X; Chen Y; Jia W; He Q; Bian Y; Wang M; Guo X; Kang J; Wan X
    Cell Death Dis; 2020 Jun; 11(6):473. PubMed ID: 32555178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription.
    Zhang H; Liu W; Wang Z; Meng L; Wang Y; Yan H; Li L
    Tumori; 2018 Jun; 104(3):221-231. PubMed ID: 29714661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.
    Pan X; Li D; Huo J; Kong F; Yang H; Ma X
    Cell Death Dis; 2018 Feb; 9(3):303. PubMed ID: 29467441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
    Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
    Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-methylation-mediated silencing of miR-7-5p promotes gastric cancer stem cell invasion via increasing Smo and Hes1.
    Xin L; Liu L; Liu C; Zhou LQ; Zhou Q; Yuan YW; Li SH; Zhang HT
    J Cell Physiol; 2020 Mar; 235(3):2643-2654. PubMed ID: 31517391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.